Pain management at the end of life: A comparative study of cancer,dementia,and chronic obstructive pulmonary disease patients

Abstract

Background:

Limited data exist concerning the unique pain characteristics of patients with non-cancer terminal diseases referred for inpatient hospice care.

Aims:

To define the unique pain characteristics of patients admitted to an acute inpatient hospice setting with end-stage dementia or chronic obstructive lung disease (or chronic obstructive pulmonary disease) and to compare them to patients with end-stage cancer.

Design:

Retrospective patient chart review. Demographic, physiological, pain parameters, and medication utilization data were extracted. Associations between pain characteristics, medication utilization, and admission diagnoses were assessed. Analyses included descriptive statistics.

Setting/participants:

In total, 146 patients admitted to an acute inpatient hospice between 1 April 2011 and 31 March 2012 with an underlying primary diagnosis of chronic obstructive pulmonary disease (n = 51), dementia (n = 48), or cancer (n = 47).

Results:

Pain was highly prevalent in all diagnostic groups, with cancer patients experiencing more severe pain on admission. Cancer patients received a significantly higher cumulative opioid dose compared with dementia and chronic obstructive pulmonary disease patients. Pain control within 24 h of pain onset was achieved in less than half of all patient groups with chronic obstructive pulmonary disease patients the least likely to achieve pain control.

Conclusions:

Despite the fact that pain is the most common complaint at the end of life, pain management may be suboptimal for some primary diagnoses. Admission diagnosis is the strongest predictor of pain control. Patient with cancer achieve the best pain control, and chronic obstructive pulmonary disease patients are the least likely to have their pain adequately treated.

Keywords

Pain management palliative care chronic obstructive pulmonary disease dementia cancer opiates

Get full access to this article

View all access options for this article.

References

Strassels

Blough

Hazlet

. Pain, demographics, and clinical characteristics in persons who receive hospice care in the United States. J Pain Symptom Manage 2006; 32: 519–531.

Steinhauser

Arnold

Olsen

. Comparing three life-limiting diseases: does diagnosis matter or is sick, sick? J Pain Symptom Manage 2011; 42: 331–341.

McMillan

Tittle

. A descriptive study of the management of pain and pain-related side effects in a cancer center and a hospice. Hosp J 1995; 10: 89–107.

Kutner

Kassner

Nowels

. Symptom burden at the end of life: hospice providers’ perceptions. J Pain Symptom Manage 2001; 21: 473–480.

Claessens

Lynn

Zhong

. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc 2000; 48: S146–S153.

Brooksbank

. Palliative care: where have we come from and where are we going? Pain 2009; 144: 233–235.

National Vital Statistics Reports. Deaths, preliminary data for 2011, http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf (2014, accessed 1 February 2014).

2012 Alzheimer’s disease facts and figure, http://www.alz.org/downloads/facts_figures_2012.pdf (2012, accessed 1 February 2014).

Connor

Tecca

Lund Person

. Measuring hospice care: the National Hospice and Palliative Care Organization National Hospice Data Set. J Pain Symptom Manage 2004; 28: 316–328.

10.

Hendriks

Smalbrugge

Hertog

. Dying with dementia: symptoms, treatment, and quality of life in the last week of life. J Pain Symptom Manage 2014; 47: 710–720.

11.

Van der Steen

. Dying with dementia: what we know after more than a decade of research. J Alzheimers Dis 2010; 22: 37–55.

12.

HajGhanbari

Holsti

Road

. Pain in people with chronic obstructive pulmonary disease (COPD). Respir Med 2012; 106: 998–1005.

13.

Solano

Gomes

Higginson

. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31: 58–69.

14.

ICD-9-CM International Classification of Diseases, 9th Revision, Clinical Modification. 5th ed. Los Angeles, CA: Practice Management Information Corporation, 1997.

15.

Mor

Laliberte

Morris

. The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002–2007.

16.

Pereira

Lawlor

Vigano

. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage 2001; 22(2): 672–687.

17.

De Conno

Caraceni

Gamba

. Pain measurement in cancer patients: a comparison of six methods. Pain 1994; 57: 161–166.

18.

Farrar

Portenoy

Berlin

. Defining the clinically important difference in pain outcome measures. Pain 2000; 88: 287–294.

19.

Farrar

. What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain 2000; 16: S106–S112.

20.

Warden

Hurley

Volicer

. Development and psychometric evaluation of the PAINAD (Pain Assessment in Advanced Dementia). J Am Med Dir Assoc 2003; 20(1): 31–43.

21.

Smith

. Pain assessment in nonverbal older adults with advanced dementia. Perspect Psychiatr Care 2005; 41(3): 99–113.

22.

Russell

Aveyard

Oxenham

. An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symptom Manage 2006; 32: 581–588.

23.

Strassel

Bluogh

Veenstra

. Clinical and demographic characteristics help explain variations in pain at the end of life. J Pain Symptom Manage 2008; 35: 10–19.

24.

Shega

Hougham

Stocking

. Patients dying with dementia: experience at the end of life and impact of hospice care. J Pain Symptom Manage 2008; 35: 499–507.

25.

SUPPORT principal investigators: a controlled trial to improve care for seriously ill hospitalized patients. JAMA 1995; 274: 1591–1598.

26.

Steindal

Bredal

Wergeland

. Pain control at the end of life: a comparative study of hospitalized cancer and noncancer patients. Scand J Caring Sci 2011; 25: 771–779.

27.

Klinkenberg

Willems

van der Wal

. Symptom burden in the last week of life. J Pain Symptom Manage 2004; 27: 5–13.

28.

Kutner

Bryant

Beaty

. Time course and characteristics of symptom distress and quality at the end of life. J Pain Symptom Manage 2007; 34: 227–236.

29.

Brorson

Plymoth

Örmon

. Pain relief at the end of life: nurses’ experiences regarding end-of-life pain relief in patients with dementia. Pain Manag Nurs 2014; 15(1): 315–323.

30.

Wilkie

Ezenwa

. Pain and symptom management in palliative care and at end of life. Nurs Outlook 2012; 60: 357–364.

31.

Bentsen

Rustøen

Miaskowski

. Differences in subjective and objective respiratory parameters in patients with chronic obstructive pulmonary disease with and without pain. Int J Chron Obstruct Pulmon Dis 2012; 7: 137–143.

32.

Spathis

Booth

. End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis 2008; 3: 11–29.

33.

Gordon

Dahl

Miaskowski

. American Pain Society recommendations for improving the quality of acute and cancer pain management. Arch Intern Med 2005; 165: 1574–1580.

34.

Gordon

Rees

McCausland

. Improving reassessment and documentation of pain management. Jt Comm J Qual Patient Saf 2008; 34: 509–517.

35.

Ellershaw

Smith

Overril

. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage 2001; 21: 12–17.

36.

Rocker

Horton

Currow

. Palliation of dyspnea in advanced COPD: revisiting a role for opioids. Thorax 2009; 64: 910–915.

37.

Mahler

Selecky

Harrod

. American College of Chest Physicians consensus statement on the management of dyspnea in patient with advanced lung or heart disease. Chest 2010; 137(3): 674–691.

38.

Stirling

Kurowska

Tookman

. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 1999; 17: 363–368.

39.

Prommer

. Role of haloperidol in palliative medicine: an update. Am J Hosp Palliat Care 2012; 29: 295–301.